We focus exclusively on meeting the needs of ultra-high-net-worth individuals, family offices, endowments and foundations, ...

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

WNS today announced that it has won five awards at the 2025 Artificial Intelligence Excellence Awards presented by Business ...